Staburo’s Managing Director Roland Stieger joined the BIO-Europe two weeks ago and enjoyed the great networking opportunities of this partnering conference with over 5000 delegates!
In addition to several one-on-one meetings, in which Roland discussed data science challenges of potential partners, we were very happy to have our brand and company information shared at the Bavarian booth, thanks to Bio-M.
The event featured several talks and a poster session. Invited speakers included Torsten Hothorn from the University of Zurich, who presented a tutorial on “A transformation perspective on Survival Analysis”; Torben Martinussen from the University of Copenhagen, who discussed “Subtleties in the interpretation of hazard ratios”; and Jan Feifel from Merck Healthcare KGaA, who spoke about “Real world evidence supporting clinical development in Oncology”.
O’ zapft is or was – the Staburo annual Wiesn event took place a few days ago. The Oktoberfest is one of Staburo’s annual team events.
This year we were lucky again and had enough tables (70 seats) for the whole team and long-time customers in the Braurösl tent. We are looking back to an entertaining evening including, singing, and dancing within the tent and to some exciting roller coaster rides for some of our colleagues.
Our core purpose at Staburo is: Excellent data science to improve and save lives. To follow our purpose and to inspire others – a part of our Staburo team will provide insights on Staburo’s core business and expertise, the development of our company as well as interesting opportunities within our company.
The 44th Annual Conference of the International Society for Clinical Biostatistics (ISCB) took place in Milan from the 27th to the 31st of August, and Staburo was there to be part of it. Four team members attended the conference, with two of them presenting posters.
Staburo GmbH Head of Biostatistics and Managing Director, Hannes Buchner, will present the research project “Deriving interpretable thresholds for Variable Importance in Random Forests by permutation” during the high-dimensional analysis session at the Central European Network (CEN) conference. This year, the conference is being held in Basel, Switzerland, and the presentation is scheduled for the 6th of September at 9:10 am.
Of course, our running and walking event could not be missing in our Staburo team event series this year either. It was already the third self-organized company run. End of July on a summer day with mixed weather forecast, around 30 colleagues of our team met at English garden for the annual run and walk event.
Staburo has been working reliably and very well in data science projects with CRS – Clinical Research Services Management GmbH – for several years now.
In this context, it is an honour to announce that Staburo is one of CRS official network partners, together with Physiogenex and FGK, which are also shown on the CRS website.
A couple of weeks ago, from 11th to 14th of June the PSI 2023 was held in Hammersmith, London. The conference is regarded as the principal annual event of the statisticians of the pharmaceutical industry and was therefore fully packed with amazing presentations and high-quality posters. Not only during the social events like the evening in the pub or the gala dinner, but also between sessions there were a lot of opportunities for networking, exchanging ideas and meeting like-minded colleagues.
A few days ago the time had come for our Staburo summer party.
On a late Wednesday afternoon all Staburo employees including families met at the event location Rothof in Munich Bogenhausen.
The day started with mixed weather, but right at the start of our event it was dry, sunny and warm.
The study was the largest prospective study to date assessing the combination of anti-programmed cell death protein 1 (PD-1) antibodies and multikinase inhibitors. This combination has shown encouraging activity in several tumour types, including colorectal cancer. In this study, 5 of 70 treated patients had a partial response, corresponding to an objective response rate of 7%.
Staburo Senior Data Scientist, Stephan Bischofberger, will be presenting at this event. He will share insights on his role, daily tasks, and his experience of statistics and data science within the healthcare sector. Stephan will be accompanied by Staburo working students Maria Blanco and Tim Müller. This is an excellent opportunity to gain insights into the practical implications of biostatistics in a professional context.